(Q42602721)

English

Melatonin as a therapy in REM sleep behavior disorder patients: an open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation

scientific article published on May 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Melatonin as a therapy in REM sleep behavior disorder patients: an open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

0 references

REM sleep behavior disorder

1 reference

based on heuristic

inferred from title

author name string

Kunz D

1

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Bes F

2

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

language of work or name

0 references

publication date

1 May 1999

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Movement Disorders

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

507-511

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder.

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C507%3A%3AAID-MDS1021%3E3.0.CO%3B2-8

21 January 2018

REM sleep behavior disorders in multiple system atrophy

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C507%3A%3AAID-MDS1021%3E3.0.CO%3B2-8

21 January 2018

Lewy body variant of Alzheimer's disease (AD) identified by postmortem ubiquitin staining in a previously reported case of AD associated with REM sleep behavior disorder.

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C507%3A%3AAID-MDS1021%3E3.0.CO%3B2-8

21 January 2018

Incidental Lewy body disease in a patient with REM sleep behavior disorder

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C507%3A%3AAID-MDS1021%3E3.0.CO%3B2-8

21 January 2018

Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C507%3A%3AAID-MDS1021%3E3.0.CO%3B2-8

21 January 2018

Dream phenomena induced by chronic levodopa therapy

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C507%3A%3AAID-MDS1021%3E3.0.CO%3B2-8

21 January 2018

Beta-blockers and sleep: a controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C507%3A%3AAID-MDS1021%3E3.0.CO%3B2-8

21 January 2018

Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults.

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C507%3A%3AAID-MDS1021%3E3.0.CO%3B2-8

21 January 2018

Melatonin effects in a patient with severe REM sleep behavior disorder: case report and theoretical considerations.

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C507%3A%3AAID-MDS1021%3E3.0.CO%3B2-8

21 January 2018

Comparison of the effects of acute fluvoxamine and desipramine administration on melatonin and cortisol production in humans.

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C507%3A%3AAID-MDS1021%3E3.0.CO%3B2-8

21 January 2018

Treatment with beta-adrenoceptor blockers reduces plasma melatonin concentration

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C507%3A%3AAID-MDS1021%3E3.0.CO%3B2-8

21 January 2018

Nonsteroidal anti-inflammatory drugs affect normal sleep patterns in humans

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C507%3A%3AAID-MDS1021%3E3.0.CO%3B2-8

21 January 2018

Effects of exposure to 16.7 Hz magnetic fields on urinary 6-hydroxymelatonin sulfate excretion of Swiss railway workers.

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C507%3A%3AAID-MDS1021%3E3.0.CO%3B2-8

21 January 2018

Polysomnographic features of REM sleep behavior disorder: Development of a scoring method

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C507%3A%3AAID-MDS1021%3E3.0.CO%3B2-8

21 January 2018

Sleep-inducing effects of low doses of melatonin ingested in the evening

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C507%3A%3AAID-MDS1021%3E3.0.CO%3B2-8

21 January 2018

Homeostatic versus circadian effects of melatonin on core body temperature in humans

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C507%3A%3AAID-MDS1021%3E3.0.CO%3B2-8

21 January 2018

Melatonin: role in gating nocturnal rise in sleep propensity

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C507%3A%3AAID-MDS1021%3E3.0.CO%3B2-8

21 January 2018

Melatonin and the circadian regulation of sleep initiation, consolidation, structure, and the sleep EEG.

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C507%3A%3AAID-MDS1021%3E3.0.CO%3B2-8

21 January 2018

Altered 5-HT metabolism with clonazepam, diazepam and diphenylhydantoin

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C507%3A%3AAID-MDS1021%3E3.0.CO%3B2-8

21 January 2018

Delayed sleep phase syndrome response to melatonin

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C507%3A%3AAID-MDS1021%3E3.0.CO%3B2-8

21 January 2018

Melatonin shifts human circadian rhythms according to a phase-response curve

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C507%3A%3AAID-MDS1021%3E3.0.CO%3B2-8

21 January 2018

Chronobiotics--drugs that shift rhythms

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C507%3A%3AAID-MDS1021%3E3.0.CO%3B2-8

21 January 2018

Commentary: evidence for melatonin as a circadian phase-shifting agent

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C507%3A%3AAID-MDS1021%3E3.0.CO%3B2-8

21 January 2018

Circadian rhythms in mammalian neurotransmitter receptors

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C507%3A%3AAID-MDS1021%3E3.0.CO%3B2-8

21 January 2018

Melatonin: A chronobiotic with anti-aging properties?

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C507%3A%3AAID-MDS1021%3E3.0.CO%3B2-8

21 January 2018

Suppression of plasma melatonin by a single dose of the benzodiazepine alprazolam in humans

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C507%3A%3AAID-MDS1021%3E3.0.CO%3B2-8

21 January 2018

Identifiers

10.1002/1531-8257(199905)14:3<507::AID-MDS1021>3.0.CO;2-8

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42602721&oldid=1962573586"